IL-25对过敏性哮喘嗜酸粒细胞祖细胞的动员作用
该研究纳入14例过敏性哮喘患者,于过敏原激发前后检测血EoP表面IL-17RB表达及迁移能力,并在OVA哮喘小鼠中验证敲除IL-25后新生Eos变化。结果显示激发后表达IL-17RB的EoP显著增加,IL-25预处理增强EoP对SDF-1α的迁移,敲除IL-25减轻气道Eos浸润及骨髓新生Eos。提示IL-25参与过敏原诱导的EoP迁移、局部分化和气道嗜酸性细胞增多。
要点
- 过敏原激发后哮喘患者血表达IL-17RB的EoP显著增加。
- IL-25预处理增强EoP对SDF-1α的迁移反应。
- 敲除IL-25减轻OVA小鼠气道及骨髓新生Eos。
核心结论
- IL-25在过敏原诱导的EoP气道迁移、局部分化和组织嗜酸性细胞增多中具有重要作用。
研究设计与样本
- 纳入2017—2018年门诊14例过敏性哮喘患者,激发前和激发后24 h采血。
- 流式细胞术检测EoP表面IL-17RA和IL-17RB表达,迁移小室评估HPC和EoP趋化迁移能力。
- 动物实验按是否敲除IL-25及是否OVA致敏激发分为哮喘组、对照组、敲除后哮喘组和敲除后对照组。
- 采集小鼠肺组织、BALF及骨髓组织,评估气道炎症及新生和成熟Eos数量。
主要发现
- 过敏性哮喘患者吸入过敏原24 h后,外周血表达IL-17RB的EoP数量显著增加[激发前后分别为(514±138)和(1146±450)/10^6个白细胞,F=6.819,P=0.022]。
- IL-25预处理后EoP在SDF-1α作用下的迁移细胞比例增加[SDF-1α组和IL-25组(1 ng/L)分别为(39.0±10.1)%和(73.0±7.9)%,P=0.021,95%CI 5.19%~58.45%]。
- OVA致敏激发小鼠中,敲除IL-25显著减轻BALF中Eos细胞比例[哮喘组与敲除后哮喘组分别为(7.8±2.0)%和(3.1±0.6)%,P=0.002,95%CI -7.57%~-1.98%]。
- 敲除IL-25降低BALF中Brdu阳性Eos细胞比例[哮喘组与敲除后哮喘组分别为(50.0±7.6)%和(8.6±4.3)%,P=0.011,95%CI -72.41%~-10.27%]。
- 敲除IL-25降低骨髓中Brdu阳性Eos细胞比例[哮喘组与敲除后哮喘组分别为(70.8±6.1)%和(1.3±1.3)%,P=0.000,95%CI -94.88%~-44.18%]。
临床怎么用
- IL-25/IL-17RB轴可能作为过敏性哮喘嗜酸性炎症的潜在干预靶点。
- EoP表面IL-17RB表达及迁移反应可作为评估过敏原诱导嗜酸性炎症的探索性指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: Eosinophil progenitor cells (EoP) play a critical role in allergic airway inflammation in asthma. Previous studies have revealed that the expression of IL-25 receptor subunits (IL-17RA and IL-17RB) are increased on eosinophils (Eos) from allergic asthmatics upon allergen inhalation but few study has explored the role of IL-25 on EoP. Thus, in this research we examined the possible role of IL-25 on EoP in allergic asthmatics challenged by allergen, as well as in animal models where we verified the changes of newly produced Eos after IL-25 knockout. Methods: Asthmatics (n=14, during 2017-2018) who developed allergen-induced early and late responses were enrolled in this study. Blood was collected at pre-and 24 h post-challenge. Surface expression of IL-17RA and IL-17RB were evaluated by flow cytometry on EoP. In vitro migration assay was used to examine migrational responses of EoP and hematopoietic cells (HPC) from these subjects. In animal models, mice were grouped according to whether IL-25 was knock-out and whether mice were sensitized and challenged by ovalbumin (OVA) into asthmatic, control, knockout asthmatic and knockout control groups. Lung tissues, bronchoalveolar lavage flow (BALF) and bone marrow tissues of these mice were collected in order to evaluate airway inflammation and amount of newly produced (Brdu positive) and mature Eos. Results: EoP expressing IL-17RB were significantly increased after allergen inhalation in allergic asthmatics [(514±138) vs. (1146±450)/10(6) cells, pre-and post-challenge, F=6.819, P=0.022]. Pre-exposure to IL-25 primed the migrational responsiveness of EoP to stromal cell-derived factor (SDF)1α [(39.0±10.1)% vs. (73.0±7.9)%, control and IL-25 exposure groups respectively, P=0.021, 95% CI 5.19%~58.45%]. In OVA sensitized mice, knockout of IL-25 significantly reduced Eos and newly produced Eos percentage in the BALF [Eos, (7.8±2.0)% vs. (3.1±0.6)%, asthmatic and knockout asthmatic group respectively, P=0.002, 95% CI-7.57% to -1.98%; Brdu positive Eos, (50.0±7.6)% vs. (8.6±4.3)%, asthmatic and knockout asthmatic group respectively, P=0.011, 95% CI-72.41% to -10.27%], and newly produced Eos were also reduced in the bone marrow [(70.8±6.1)% vs. (1.3±1.3)%, asthmatic and knockout asthmatic group respectively, P=0.000, 95% CI -94.88% to -44.18%]. Conclusion: These results suggest an important role of IL-25 in allergen-induced EoP migration, local differentiation and eosinophilia in the airways. 目的: 探讨IL-25在过敏原诱发的支气管哮喘(哮喘)患者中对嗜酸粒细胞系祖细胞(EoP)增殖、迁移反应,并在动物实验中验证敲除IL-25后哮喘小鼠新生嗜酸粒细胞的变化。 方法: 对2017—2018年期间我院门诊14例哮喘患者分别于过敏原激发前和激发后24 h采血,通过流式细胞术检测哮喘患者过敏原激发前后EoP表面IL-17RA和IL-17RB的表达水平,然后分选出造血祖细胞(HPC)和EoP细胞通过迁移小室评估其趋化迁移能力。在动物模型实验中,根据是否敲除IL-25和通过卵清白蛋白(OVA)致敏激发将小鼠分为哮喘组、对照组、敲除后哮喘组和敲除后对照组,采集小鼠肺组织、肺泡灌洗液(BALF)及骨髓组织并评估其气道炎症、新生和成熟嗜酸粒细胞(Eos)数量等。 结果: 过敏性哮喘患者吸入过敏原24 h后,外周血表达IL-25高亲和力受体IL-17RB的EoP数量显著增加[激发前后分别为(514±138)和(1 146±450)/10(6)个白细胞,F=6.819,P=0.022]。IL-25预处理后可增加EoP在祖细胞趋化剂基质细胞衍生因子1α(SDF-1α)的作用下于迁移小室中的迁移细胞比例[SDF-1α组和IL-25组(1 ng/L)分别为(39.0±10.1)%和(73.0±7.9)%,P=0.021]。在OVA致敏和激发小鼠中,敲除IL-25显著减轻了OVA诱导的气道Eos细胞浸润[哮喘组与敲除后哮喘组BALF中Eos细胞比例分别为(7.8±2.0)%和(3.1±0.6)%,P=0.002]和肺内新生的Eos细胞数目[哮喘组与敲除后哮喘组BALF中Brdu阳性Eos细胞分别为(50.0±7.6)%和(8.6±4.3)%,P=0.011]及肺组织炎症[哮喘组与敲除后哮喘组肺组织炎症指数分别为(1.63±0.11)和(0.93±0.10),P=0.000],同时也降低了骨髓新生Eos的数量[哮喘组与敲除后哮喘组骨髓中Brdu阳性Eos细胞分别为(70.8±6.1)%和(1.3±1.3)%,P=0.000]。 结论: IL-25在过敏原诱导的EoP气道迁移、局部分化和组织嗜酸性细胞增多中具有重要作用。.
引用
- Du W, Du J, Zhou J, et al. [The mobilization effect of IL-25 on eosinophil progenitor cells in allergic asthma]. Zhonghua Jie He He Hu Xi Za Zhi. 2019. PMID: 31365968. doi:10.3760/cma.j.issn.1001-0939.2019.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。